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ABSTRACT
Aim: Vitamin D deficiency impairs the immunological system and has been associated with
worseoutcomesof infectiousdiseases, but its role inbacterialmeningitis remainsunknown.We
investigated whether serum 25-hydroxyvitamin D concentrations related to disease outcomes
and to cerebrospinal fluid (CSF) cathelicidin concentrations in childhood bacterial meningitis.
Methods: All consecutively enrolled patients in a clinical trial on childhood bacterial
meningitis in Latin America in 1996–2003 were considered, and 142 children, with a
median age of seven months who had a confirmed bacterial aetiology and frozen serum
available for further analyses, were included in this study. Serum 25-hydroxyvitamin D
concentrations were determined with a chemiluminescence immunoassay analyser, while
CSF cathelicidin was measured by enzyme-linked immunosorbent assay.
Results: The median serum 25-hydroxyvitamin D concentration was 96 (range 19–251)
nmol/L. No relationship was found with patient survival, but children with any neurological
sequelae had lower serum 25-hydroxyvitamin D levels than children without sequelae.
Serum 25-hydroxyvitamin D was unrelated to cathelicidin concentrations in CSF.
Conclusion: Although serum 25-hydroxyvitamin D in children with bacterial meningitis was
not associated with survival or CSF cathelicidin concentrations, its relationship with more
detailed disease outcomes warrants further study.
INTRODUCTION
Vitamin D is well known for its vital role in bone
homeostasis, but it also exerts multiple functions in the
immune system (1). For example, it directly promotes the
gene expression of the antimicrobial peptide cathelicidin
(LL-37) by activating the vitamin D receptor, best docu-
mented in macrophages and monocytes (2–4). In general,
vitamin D seems to shift the immune response towards a
more tolerogenic state, acting through cells in both the
innate and the adaptive immune systems (1).
Convincing data exist on the role of vitamin D in the host
defence against Mycobacterium tuberculosis. Dating back
to the pre-antibiotic era, tuberculosis was successfully
treated with cod liver oil supplements and sunshine therapy
(5–7). Vitamin D deficiency was later associated with
increased mortality and risk of sepsis in critically ill adults
(8,9), as well as with an increased rate of respiratory tract
infections (10). However, the effect of vitamin D
supplements on the occurrence and outcomes of infectious
diseases seems less clear (11,12).
Vitamin D-deficient mice with induced bacterial menin-
gitis died earlier than those with higher vitamin D levels
(13). As the mice with higher vitamin D levels released
more anti-inflammatory interleukin-10 and less pro-inflam-
matory interleukin-6, it raises the question about whether
vitamin D would have a regulatory function in the immune
response to bacterial meningitis? This question is even
Abbreviations
CSF, Cerebrospinal fluid; IQR, Interquartile range; S-25-OHD,
Serum 25-hydroxyvitamin D.
Key notes
 The relationship between vitamin D with cerebrospinal
fluid (CSF) cathelicidin and the disease outcomes in
children with bacterial meningitis remains unknown.
 Our study of 142 children with bacterial meningitis
showed a median serum 25-hydroxyvitamin D concen-
tration of 96 nmol/L, which did not relate to patient
survival or CSF cathelicidin levels.
 Surviving children with any neurological sequelae had
lower serum 25-hydroxyvitamin D levels compared to
children without sequelae.
©2018 Foundation Acta Pædiatrica. Published by John Wiley & Sons Ltd 2018 107, pp. 2131–2136 2131
Acta Pædiatrica ISSN 0803-5253
more relevant, as the extent of the host reaction in bacterial
meningitis is probably pivotal in the outcomes of this
disease. One study reported that vitamin D deficiency in
microglial cultures unexpectedly resulted in a decreased
release of interleukin-6, a reduced phagocytosis and the
reduced ability of cells to kill bacteria (14). In a clinical
setting, vitamin D deficiency did not relate to the develop-
ment or fungal clearance of cryptococcal meningitis (15),
but its role in bacterial meningitis remains unstudied.
This contradictory information encouraged us to clarify
the role of vitamin D in childhood bacterial meningitis, and
we hypothesised that vitamin D might relate to disease
outcomes. We therefore compared the serum 25-hydro-
xyvitamin D (S-25-OHD) concentrations in children with
bacterial meningitis to different outcomes of the disease.
We also investigated whether S-25-OHD correlated with
cathelicidin levels in cerebrospinal fluid (CSF).
PATIENTS AND METHODS
Our group conducted a large prospective and double-blind
treatment trial on childhood bacterial meningitis in Latin
America from 1996 to 2003, focusing on the effects of
adjuvant dexamethasone and glycerol (16). In the partici-
pating centres, all consecutive patients with suspected
bacterial meningitis aged from two months to 16 years
were assessed for eligibility. CSF was collected on admis-
sion to hospital and 12–24 hours later, whereas the serum
samples were collected on admission and later if clinically
required. This study included the patients with an aetiolog-
ically confirmed bacterial meningitis and frozen serum
samples that could be used to determine S-25-OHD levels.
The study protocol was approved by the ethics committees
of all the study hospitals (16).
The patients’ presenting clinical conditions were evalu-
ated using the Glasgow Coma Scale, while their nutritional
status was evaluated in terms of weight for age and
converted to Z-scores according to World Health Organi-
zation standards. Severe neurological sequelae included
blindness, quadriplegia or quadriparesis, severe psychomo-
tor retardation or hydrocephalus requiring a shunt, while
any neurological sequelae also comprised milder neurolog-
ical findings such as monoparesis or hemiparesis, ataxia and
moderate psychomotor retardation. Hearing deficits were
not included in these definitions.
Special attention was paid to hearing impairment. At
discharge from hospital, all children were tested, each ear
separately, using traditional or brainstem evoked response
audiometry. Deafness was defined as a bilateral hearing
threshold of at least 80 decibels, and the audiological
outcome was further assessed as the sum of the hearing
threshold of both ears. Moreover, the patients were cate-
gorised using the hearing of the better ear into five ordinal
categories. Finally, the summary outcome was graded using
the Glasgow Outcome Scale.
Serum 25-hydroxyvitamin D was analysed using the
fullyautomated immunoassayIDS-iSYSsystem(Immunodiag-
nostic Systems, Tyne andWear, UK) with chemiluminescence
detection with an intra-assay variation of less than 5%. The
IDS-iSYS system has shown a good linear agreement with
liquid chromatography in tandem with mass spectrometry
(R² = 0.942) based on an in-house comparison performedwith
67samples.Thequalityandaccuracyof theS-25-OHDanalysis
are validated on an ongoing basis by participation in the
VitaminDExternalQualityAssessmentScheme,which is co-
ordinated by Charing Cross Hospital, London, UK. The
method has showed a 3% positive bias against all laboratory
trimmedmean values and a 10%positive bias comparedwith
National Institute of Standards and Technology standards in
international comparisons (17). It has been noted that there
has been a minor tendency to overestimate the actual
concentration.
If two or more serum samples were available, the mean
value of the S-25-OHD concentration was taken into
account. The patient’s vitamin D status was examined by
using both the continuous S-25-OHD concentration and
the S-25-OHD concentration when it was categorised into
groups: S-25-OHD concentrations of less than 50 nmol/L
were defined as deficient and more than 125 nmol/L were
regarded to be excessive (18). In addition, a cut-off value of
75 nmol/L was used to examine the potential beneficial
effects of higher S-25-OHD levels (19). The cathelicidin
concentrations had previously been assessed by enzyme-
linked immunosorbent assay in the CSF of a subgroup of
patients, using the commercially available Human LL-37
ELISA Kit (Hycult Biotech, Uden, the Netherlands) (20).
In all, 142 children (59%male) were included in the study,
with a median age of seven months. They originated from
SantoDomingo in theDominican Republic (n = 85), Guaya-
quil in Ecuador (n = 41) and Barquisimeto in Venezuela
(n = 16). The causative agents of their bacterial meningitis
wereHaemophilus influenzae type b (n = 81), Streptococcus
pneumoniae (n = 43), Neisseria meningitidis (n = 9), Sal-
monella spp. typeD (n = 5), Streptococcus agalactiae (n = 2)
and Haemophilus influenzae type a (n = 2). The patient
characteristics are summarised in Table 1.
Statistical methods
The normality of variables was visually inspected. First, we
compared S-25-OHD concentrations with the baseline
patient characteristics. We then projected S-25-OHD con-
centrations against different disease outcomes, including
death, occurrence of severe or any neurological sequelae,
deafness, the hearing threshold measured at discharge and
the outcome in terms of the Glasgow Outcome Scale score.
Finally, we investigated whether the CSF cathelicidin
concentrations on admission, or during treatment, were
associated with S-25-OHD.
Statview software version 5.0.1 (SAS Institute, Cary, NC,
USA) was used for the statistical analysis. Spearman’s rank
correlation, the Mann–Whitney U-test and the Kruskal–
Wallis test were used to compare the vitamin D levels with
patient characteristics, disease outcomes and the CSF
cathelicidin levels. The chi-square test was applied when
we compared the categorical variables, while multivariate
analyses were conducted with multiple regression analysis.
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P values of less than 0.05 were considered statistically
significant, using the Bonferroni corrections in multiple
comparisons.
RESULTS
Serum vitamin D levels and baseline characteristics
The analyses were based on 142 patients. The median S-25-
OHD concentration was 96 nmol/L, with an interquartile
range (IQR) of 80–119 nmol/L: five patients (4%) had
S-25-OHD levels below 50 nmol/L, while the vitamin D
concentration exceeded 125 nmol/L in 31 patients (22%)
(Fig. 1). Deficient vitamin D levels (S-25-OHD <50 nmol/
L) were associated with younger patient age (p = 0.03),
lower weight-for-age Z-scores (p = 0.02) and lower blood
glucose levels on admission (p = 0.005), while excessive
S-25-OHD (>125 nmol/L) related to a lower CSF glucose
on admission (p = 0.03).
When we looked at S-25-OHD as a continuous variable,
children from Ecuador showed significantly lower S-25-
OHD concentrations than children from Venezuela and the
Dominican Republic (p < 0.001; Fig. 2). Moreover, lower
S-25-OHD related to a higher CSF glucose (q = 0.197,
p = 0.03) and a higher serum sodium level (q = 0.199,
p = 0.04) on admission. However, in a multivariate regres-
sion model with the country of origin, serum sodium level
and CSF glucose, only the country of origin remained a
significant predictor of S-25-OHD. No other associations
between the vitamin D concentrations and the patient
characteristics were found (Table 1).
Serum vitamin D levels and disease outcomes
The S-25-OHD concentration on admission did not relate
to the child’s survival (p = 0.86), severe neurological
sequelae (p = 0.85) or deafness (p = 0.25). Moreover, the
S-25-OHD concentration was not associated with the
Table 1 Patient characteristics
Characteristic Result
Total number of patients 142
Male sex (%) 84/142 (59)
Age, median months (IQR) 7 (5–13)
Weight-for-age Z-score, median (IQR) 0.73 (1.7 to 0.3)
GCS score on admission, median (IQR) 13 (10–14)
Aetiology, number of cases
Haemophilus influenzae 81
Streptococcus pneumoniae 43
Neisseria meningitidis 9
Other 9
Prior antimicrobial treatment (%) 57/129 (44)
CSF test results on admission
Leucocyte count, median cells/lL (IQR) 2500 (920–6500)
Polymorphonuclear cells, percentage (IQR) 77.5 (56–87)
Protein level, median mg/dL (IQR) 163 (87–249)
Glucose level, median mg/dL (IQR) 15.5 (9–31)
Blood test results on admission
White cell count, median 103 cells/lL (IQR) 13.5 (8.8–19.2)
Haemoglobin level, median g/dL (IQR) 8.2 (7.3–9.3)
Glucose level, median mg/dL (IQR) 104.5 (81–136)
Sodium level, median mmol/L (IQR) 137 (135–141)
GOS score at discharge, median (IQR) 4 (3–5)
CSF = Cerebrospinal fluid; GCS = Glasgow Coma Scale; GOS = Glasgow
Outcome Scale. IQR = Interquartile range
Figure 1 Serum 25-hydroxyvitamin D concentrations.
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disease outcome in terms of the Glasgow Outcome Scale
score (q = 0.047, p = 0.60). However, surviving children
with any neurological sequelae had slightly lower S-25-
OHD concentrations than children without neurological
sequelae: the median S-25-OHD concentration was
89 nmol/L (IQR 75–111) in children with any neurological
sequelae, compared to 101 nmol/L (IQR 85–127) in chil-
dren without sequelae (p = 0.04).
A tendency for an inverse association between S-25-
OHD and hearing outcome was observed in 98 of the 119
survivors (q = 0.176, p = 0.08). In line with this, children
with S-25-OHD below 75 nmol/L seemed to develop
hearing problems to a lesser extent, in terms of the
categorised hearing of the better ear (p = 0.01). However,
when information from both ears was combined, statistical
significance was lost (p = 0.07). Deficient S-25-OHD did
not relate to the audiological outcome (p = 0.21).
Serum vitamin D and CSF cathelicidin
The CSF cathelicidin concentration had previously been
analysed in CSF in 115 samples taken at presentation and
in 76 samples taken 12–24 hours later. The median
concentrations were 35.4 ng/mL (IQR 9.0–105.5) and
7.6 ng/mL (IQR 3.3–45.5), respectively. The S-25-OHD
concentrations were not related to CSF cathelicidin in
either sample: q was 0.071 at presentation (p = 0.45) and
was 0.010 after 12–24 hours (p = 0.93). In addition, the
change in CSF cathelicidin during treatment did not relate
to the S-25-OHD concentration.
DISCUSSION
Our study presents novel data on the vitamin D status of
children with bacterial meningitis from Latin America and
suggests that serum vitamin D concentrations were mainly
sufficient and remained unassociated with patient survival.
CSF cathelicidin was not related to serum vitamin D
concentrations.
Based on the literature (8), we expected the vitamin D
status to affect the prognosis of bacterial meningitis, but
S-25-OHD was not associated with survival, severe neuro-
logical sequelae or deafness. The 40 surviving children with
any neurological sequelae at discharge had slightly lower S-
25-OHD levels than the 75 children without sequelae,
although the median S-25-OHD values were within the
normal range in both groups. Interestingly, an inverse
association was marked between S-25-OHD and the audi-
ological outcome in survivors.
Previous reports on vitamin D in hearing impairment
have shown inconsistent results. Vitamin D deficiency and
hearing deficits were linked to an older study published in
1984, and vitamin D receptor knockout mice developed
sensorineural hearing loss at an earlier age (21,22). How-
ever, since then a Korean study has reported an association
between higher serum vitamin D concentrations and worse
hearing, and a study on mice exhibiting premature ageing
syndrome demonstrated that a diet deficient in vitamin D
prevented hearing loss (23,24). Given these results, both
insufficient and excessive serum vitamin D concentrations
might contribute to the pathological processes that affect
hearing.
Obviously, our finding of lower S-25-OHD concentra-
tions relating to milder hearing impairment in children with
bacterial meningitis needs further confirmation. The toxic-
ity of higher S-25-OHD concentrations is not a possible
explanation for this finding, as we found no correlation
between excessive (>125 nmol/L) S-25-OHD and audio-
logical outcomes. Nevertheless, as the role of vitamin D has
not been previously investigated in this setting, the optimal
S-25-OHD concentration in bacterial meningitis remains
unknown.
We did not find any evidence to suggest that circulating
vitamin D levels regulated CSF cathelicidin synthesis. One
study reported a poor urine cathelicidin response in vitamin
D-deficient patients with an acute urinary tract infection
when they were compared with patients with higher serum
vitamin D levels (25). Previous studies have also suggested a
relationship between vitamin D and serum cathelicidin,
although this association seemed to disappear when vita-
min D levels were sufficient (26) Thus, given the rather high
vitamin D concentrations in our patients, the lack of an
association between vitamin D in serum and cathelicidin in
CSF was not entirely surprising. Perhaps the vitamin D
levels in our patients were sufficient to not impair the
synthesis of cathelicidin in CSF.
Compared with previous reports from the same region,
our patients showed surprisingly high serum vitamin D
levels (27). The lower concentrations in children from
Ecuador may be, at least partly, explained by geography, as
the city of Guayaquil enjoys less sunshine each year than
the other study centres in Santo Domingo in the Dominican
Republic and Barquisimeto in Venezuela (28–30). The
Figure 2 Serum 25-hydroxyvitamin D concentrations according to country of
origin. Kruskal–Wallis test, p < 0.001. Pairwise comparisons with Mann–Whitney
U-test (Bonferroni-corrected p values): Ecuador versus Venezuela, p = 0.01;
Ecuador versus Dominican Republic, p < 0.001; Venezuela versus Dominican
Republic, p = 1.0. Data are presented as Tukey’s box-and-whisker plots.
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different ethnic origins of the population may also be an
important factor, although the largest ethnic groups in all
three countries seem to be mixed race. On the other hand,
dissimilar regular supplements of vitamin D and differing
dietary habits cannot be ruled out. We assume that these
three Latin American countries were not profoundly
dissimilar in these aspects of child health.
We acknowledge that our study had some limitations.
This sample comprised a rather small group of children
from Latin America, and the low prevalence of vitamin D
deficiency may simply have been characteristic of the
studied regions. As our series only included five patients
with serum 25-OHD below 50 nmol/L, conclusions on the
role of vitamin D deficiency in the host response to
bacterial meningitis should be made with caution. Previous
studies have suggested a relationship between vitamin D
levels and disease outcomes in critically ill adults, where
poorer outcomes were associated with a concentration
somewhere below 50 nmol/L (8.9). A similar cut-off value
was also used in studies of respiratory tract infections (10).
Whether such concentrations would relate to poorer out-
comes in paediatric patients with bacterial meningitis
remains unclear, but we hypothesise that a similar associ-
ation might exist.
CONCLUSION
Altogether, our results suggest that vitamin D concentra-
tions in children with bacterial meningitis from Latin
America were mainly sufficient and were not related to
either patient survival or CSF cathelicidin concentrations.
However, the detected relationship between S-25-OHD
and both neurological and audiological outcomes warrants
further research to explore the impact of vitamin D on the
host response and outcomes of this disease.
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